Lenalidomide is active for extramedullary disease in refractory multiple myeloma

被引：14
作者：
Nakazato, Tomonori [1 ]
Mihara, Ai [1 ]
Ito, Chisako [1 ]
Sanada, Yukinari [1 ]
Aisa, Yoshinobu [1 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan
来源：
ANNALS OF HEMATOLOGY | 2012年 / 91卷 / 03期
关键词：
THALIDOMIDE; BORTEZOMIB;
D O I：
10.1007/s00277-011-1272-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [31] Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma
    Moustafa, Muhamad Alhaj
    Parrondo, Ricardo
    Abdulazeez, Mays F.
    Roy, Vivek
    Sher, Taimur
    Alegria, Victoria R.
    Warsame, Rahma M.
    Fonseca, Rafael
    Rasheed, Ahsan
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Kapoor, Prashant
    Buadi, Francis K.
    Dingli, David
    Hayman, Suzanne R.
    Reeder, Craig B.
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    ANTI-CANCER DRUGS, 2024, 35 (01) : 63 - 69
  • [32] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Pierceall, William E.
    Chung, Weiyuan
    Zafar, Faiza
    Agarwal, Amit
    Bahlis, Nizar J.
    LEUKEMIA, 2020, 34 (12) : 3286 - 3297
  • [33] Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients
    Stork, M.
    Sevcikova, S.
    Adam, Z.
    Krejci, M.
    Sandecka, V
    Kral, Z.
    Brozova, L.
    Velichova, R.
    Pour, L.
    NEOPLASMA, 2018, 65 (04) : 585 - 591
  • [34] Extramedullary involvement in multiple myeloma
    Blade, Joan
    Fernandez de Larrea, Carlos
    Rosinol, Laura
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (11): : 1618 - 1619
  • [35] An update on the use of lenalidomide for the treatment of multiple myeloma
    Zagouri, Flora
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios-Athanasios
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (12) : 1865 - 1877
  • [36] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17) : 1621 - 1634
  • [37] Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens
    Botta, Cirino
    Martino, Enrica Antonia
    Conticello, Concetta
    Mendicino, Francesco
    Vigna, Ernesto
    Romano, Alessandra
    Palumbo, Giuseppe Antonio
    Cerchione, Claudio
    Martinelli, Giovanni
    Morabito, Fortunato
    Di Raimondo, Francesco
    Gentile, Massimo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Thalidomide and lenalidomide in multiple myeloma
    Mazumder, Amitabha
    Jagannath, Sundar
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (04) : 769 - 780
  • [39] Tailoring Treatment for Multiple Myeloma Patients With Relapsed and Refractory Disease
    Richardson, Paul G.
    Laubach, Jacob
    Mitsiades, Constantine
    Schlossman, Robert L.
    Doss, Deborah
    Colson, Kathleen
    Mckenney, Mary L.
    Noonan, Kimberly
    Warren, Diane L.
    Ghobrial, Irene M.
    Munshi, Nikhil C.
    Anderson, Kenneth
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 22 - 29
  • [40] The impact of extramedullary disease at presentation on the outcome of myeloma
    Wu, Ping
    Davies, Faith E.
    Boyd, Kevin
    Thomas, Karen
    Dines, Sharon
    Saso, Radovan M.
    Potter, Mike N.
    Ethell, Mark E.
    Shaw, Bronwen E.
    Morgan, Gareth J.
    LEUKEMIA & LYMPHOMA, 2009, 50 (02) : 230 - 235
12345